Join the club for FREE to access the whole archive and other member benefits.
Partnering with Japan's DSP, a milestone is reached in OCD treatment
Key points from article :
A candidate compound found within 350 synthesised compounds (typically just 2,500).
DSP-1181, created with DSP’s monoamine G protein-coupled receptor drug discovery.
Together with Exscientia’s technology, known as Centaur Chemist.
Drug is a long-acting and potent serotonin 5-HT1A receptor agonist.
New era of AI-driven drug discovery, evolving very fast.
Research by UK- Exscientia and Japan- Sumitomo Dainippon Pharma.
Click on resource name for more details.
SULSA Research Professor of Translational Biology at the School of Life Sciences, University of Dundee
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
One of the world’s most influential cancer research organizations
